Skin deposition and permeation kinetics of cannabidiol and delta-9-tetrahydrocannabinol from cannabis extract containing gels

被引:1
|
作者
Jaipakdee, Napaphak [1 ,2 ]
Tabboon, Peera [1 ,2 ]
Pongjanyakul, Thaned [2 ]
Limpongsa, Ekapol [3 ]
机构
[1] Khon Kaen Univ, Ctr Res & Dev Herbal Hlth Prod, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Fac Pharmaceut Sci, Div Pharmaceut Technol, Khon Kaen 40002, Thailand
[3] Rangsit Univ, Coll Pharm, Pathum Thani 12000, Thailand
关键词
Cannabis sativa L; Permeation enhancers; Phytocannabinoids; Skin deposition profiles; Topical gels; Transdermal absorption; ENHANCED TRANSDERMAL DELIVERY; ISOPROPYL MYRISTATE; PERCUTANEOUS PERMEATION; RHEOLOGICAL PROPERTIES; DRUG-RELEASE; PENETRATION; TESTOSTERONE; FORMULATION; SOLUBILITY; DICLOFENAC;
D O I
10.1016/j.jddst.2024.106160
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The study aimed to investigate the deposition and permeation characteristics of phytocannabinoids, namely delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), from cannabis extract containing gels. Cannabis extract with 26.3 % CBD and 28.4 % THC was used. The impact of permeation enhancers, namely propylene glycol, diethylene glycol monoethyl ether (DEGEE), ethanol (EtOH), and terpenes (eucalyptol and menthol), was examined. All cannabis extract gels had a pH range of 6.71-6.81 and a viscosity range of 456.6-4068.7 mPa & sdot;s. The phytocannabinoid release from the gels followed Zero-order kinetics with a rate of 14.5-25.7 mu g & sdot;h(-1) for CBD and 10.0-22.6 mu g & sdot;h(-1) for THC. A gel containing 12.5 % DEGEE and 12.5 % EtOH exhibited the highest release rate. The initial skin deposition followed Zero-order kinetics and reached a maximum level after 4 h. Permeation of phytocannabinoids closely followed Higuchi kinetics, with a rate of 0.14-54.21 mu g & sdot;h(-1/2) for CBD and 0.23-67.02 mu g & sdot;h(-1/2) for THC. A gel containing 25 % DEGEE and 25 % EtOH exhibited the highest apparent skin partition coefficient (K) value, resulting in the greatest phytocannabinoid deposition and permeation. Terpene introduction (5 %) significantly reduced the release rate, K value, and total skin absorption of phytocannabinoids. These findings offer useful insights into selecting the appropriate vehicle for cannabis extract topical products.
引用
收藏
页数:14
相关论文
共 50 条
  • [11] Delta-9-Tetrahydrocannabinol acetate from acetylation of cannabis oil
    Valentine, MD
    SCIENCE & JUSTICE, 1996, 36 (03) : 195 - 197
  • [12] INTERACTIONS OF CANNABIS EXTRACT, DELTA-9-TETRAHYDROCANNABINOL AND 11-HYDROXY-DELTA-8-TETRAHYDROCANNABINOL WITH METHAMPHETAMINE IN MICE
    YAMAMOTO, I
    UMEBAYASHI, H
    WATANABE, K
    YOSHIMURA, H
    RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE, 1988, 9 (02) : 107 - 116
  • [13] EFFECT OF CANNABIS EXTRACT AND DELTA-9-TETRAHYDROCANNABINOL ON RAT-BRAIN CATECHOLAMINES
    PODDAR, MK
    GHOSH, JJ
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1976, 13 (03): : 273 - 277
  • [14] Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
    Colizzi M.
    Bhattacharyya S.
    Current Addiction Reports, 2017, 4 (2) : 62 - 74
  • [15] INFLUENCE OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL ON COBALT EPILEPSY IN RATS
    CHIU, P
    OLSEN, DM
    BORYS, HK
    KARLER, R
    TURKANIS, SA
    EPILEPSIA, 1979, 20 (04) : 365 - 375
  • [16] THE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL AND CANNABIDIOL ON BRAIN FUNCTION IN MAN
    Bhattacharyya, Sagnik
    Crippa, J. A.
    Martin-Santos, R.
    Allen, P.
    Borgwardt, S.
    Fusar-Poli, P.
    Seal, M.
    Zuardi, A. W.
    Atakan, Z.
    McGuire, P.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S26 - S26
  • [17] EFFECT OF CANNABIS EXTRACT AND DELTA-9-TETRAHYDROCANNABINOL ON BRAIN ADENOSINE-TRIPHOSPHATASE ACTIVITY
    PODDAR, MK
    GHOSH, JJ
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1976, 13 (03): : 267 - 272
  • [18] CHARACTERISTICS OF THE STIMULUS PRODUCED BY THE MIXTURE OF CANNABIDIOL WITH DELTA-9-TETRAHYDROCANNABINOL
    ZUARDI, AW
    FINKELEARB, E
    BUENO, OFA
    MUSTY, RE
    KARNIOL, IG
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1981, 249 (01): : 137 - 146
  • [19] A drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'
    Tanasescu, Radu
    Rog, David
    Constantinescu, Cris S.
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (04) : 437 - 452
  • [20] EFFECTS OF CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL ON OPERANT-BEHAVIOR
    DAVIS, WM
    BORGEN, LA
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1974, 9 (03): : 453 - 462